All News
A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps
Ready for telemedicine/telerheumatology?
Once you and your patient agree on a virtual visit, the following suggestions may help facilitate the interaction. If you have the ability and the capacity, record the visit.
The COVID-19 Global Rheumatology Registry
As the highly virulent SARS-CoV-2 spreads over the world, uncertainty and fear for our patients with rheumatic diseases mount.
Read ArticleRheumatic Disease Drugs and COVID-19
We are in the early stages of trying to limit the morbid and mortal consequences of the corona virus pandemic of 2020. Not surprisingly, the recommendations designed to limit exposure and damage continually highlight the fact that the elderly and immunosuppressed may be amongst the most severely affected should they become infected with this virus.
This has led to a great deal of uncertainty by patients and providers about how rheumatic diseases and their treatments need to be specifically addressed.
In Vasculitis, Beware of Infection
Risks of infection were strikingly high among patients with antineutrophil cytoplasmic antibody-associated (ANCA) vasculitis, which may relate to both the disease and its treatment, Scottish researchers found.
Read ArticleDr. John Cush RheumNow ( View Tweet)
Dr. John Cush RheumNow ( View Tweet)
Jonathan Hausmann MD hausmannMD ( View Tweet)
Dr. John Cush RheumNow ( View Tweet)
Dr. John Cush RheumNow ( View Tweet)
Dr. John Cush RheumNow ( View Tweet)
Dr. John Cush RheumNow ( View Tweet)
Hyper IgD syndrome. Dr. Dan Kastner #RNL2020 https://t.co/PF5TxDzvdt
Features of TRAPS. Episodes last 4 to 6 weeks. Amyloid in 10 to 15%. Dr. Dan Kastner #RNL2020 https://t.co/E3CjPa7EVA
Key features of FMF Dr. Dan Kastner #RNL2020 https://t.co/8BmXxRMvEi
5 known inflammasomes and what activates them Dr. Hal Hoffman #RNL2020 https://t.co/3qxs1c13YN
Diseases associated with NLRP3 mutations Dr Hal Hoffman #RNL2020 https://t.co/pN2c2LhjJe